In recent trading session, Agilon Health Inc (NYSE:AGL) saw 1.18 million shares changing hands at last check today with its beta currently measuring 0.40. Company’s recent per share price level of $3.94 trading at -$0.06 or -1.50% at last check today assigns it a market valuation of $1.62B. That most recent trading price of AGL’s stock is at a discount of -96.19% from its 52-week high price of $7.73 and is indicating a premium of 61.93% from its 52-week low price of $1.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.51 million shares which gives us an average trading volume of 5.29 million if we extend that period to 3-months.

For Agilon Health Inc (AGL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.86. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.01 in the current quarter.

Agilon Health Inc (NYSE:AGL) trade information

Upright in the red during last session for losing -1.50%, in the last five days AGL remained trading in the green while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $3.94 price level, adding 5.29% to its value on the day. Agilon Health Inc’s shares saw a change of 107.37% in year-to-date performance and have moved 12.25% in past 5-day. Agilon Health Inc (NYSE:AGL) showed a performance of 10.36% in past 30-days. Number of shares sold short was 16.82 million shares which calculate 2.91 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 2.75 to the stock, which implies a fall of -43.27% to its recent value today. Analysts have been projecting 2.5 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would jump 36.55% in reaching the projected high whereas dropping to the targeted low would mean a gain of 36.55% for stock’s current value.

Agilon Health Inc (AGL) estimates and forecasts

This year revenue growth is estimated to fall -0.74% from the last financial year’s standing.

16 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.5B for the same. And 16 analysts are in estimates of company making revenue of 1.48B in the next quarter. Company posted 1.6B and 1.48B of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.29% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 52.13% while estimates for its earnings growth in next 5 years are of 51.97%.

Agilon Health Inc (NYSE:AGL)’s Major holders

Insiders are in possession of 1.81% of company’s total shares while institution are holding 95.60 percent of that, with stock having share float percentage of 97.36%. Investors also watch the number of corporate investors in a company very closely, which is 95.60% institutions for Agilon Health Inc that are currently holding shares of the company. CLAYTON, DUBILIER & RICE, LLC is the top institutional holder at AGL for having 100.0 million shares of worth $654.0 million. And as of 2024-06-30, it was holding 24.3149 of the company’s outstanding shares.

The second largest institutional holder is FMR LLC, which was holding about 56.93 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.8418 of outstanding shares, having a total worth of $372.3 million.

On the other hand, Vanguard Specialized-Health Care Fund and Smallcap World Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024, the former fund manager was holding 38.68 shares of worth $152.98 million or 9.38% of the total outstanding shares. The later fund manager was in possession of 30.92 shares on Dec 31, 2024, making its stake of worth around $122.28 million in the company or a holder of 7.50% of company’s stock.